Heritage Global Partners is selling laboratory and biopharma R&D assets from Pfizer.
Multinational biotechnology and pharmaceutical firm Pfizer was founded in 1849. The company develops and manufactures health care products and devices. These include vaccines, and medicines used in oncology, neurology, endocrinology and immunology.
The online auction begins on the 23rd of February and closes on the 24th of February. Equipment available in sale includes: mass spectrometers; assorted analyzers; GC systems; spectrophotometers; HPLC systems; spectrometers; analytical and top-load balances; liquid handling system; dissolution systems; vacuum pumps; microscopes; robotic workstations; general laboratory refrigerators and freezers; ULT freezers; centrifuges; incubators; consumables and disposables, and much more.
The assets are located in Groton, Connecticut and can be inspected by appointment with the auctioneer only.
Asset advisory and full-service auction firm Heritage Global Partners operates across more than 25 industries, including the oil and gas, pharmaceutical, automotive and food and beverage sectors. The firm conducts around 150-200 auctions every year – ranging from single asset dispositions to entire turnkey facilities and complete factories.
For further information about this, or any other Heritage Global Partners auction, please visit: